-
The 6th China International Import Expo showcases its attractiveness, and Boston's science is being updated on a large scale
Bringing all the products that have won the Galen Award or been nominated by him over the years to the CIIE, bringing all the new products developed globally to the stage of CIIE. Many of the exhibit ... -
Boston Science Holds an Innovative Product Promotion Conference at the 6th CIIE with 5 New Products
On November 6th, Boston Science held an innovative product promotion event at the 6th China International Import Expo (hereinafter referred to as the "Import Expo"), focusing on five heavyweight inno ... -
Boston Science announces agreement to acquire medical technology company Axonics for $71 per share
On January 10th, Boston Scientific announced that it had recently signed the final agreement for the acquisition of Axonics, Inc. The acquisition price is $71 per share, traded in cash, with an equit ... -
The first production and manufacturing base of Boston Scientific China has opened
On October 15th, the first production and manufacturing base of Boston Scientific China opened in Lingang, Shanghai. This is an important component of Boston Scientific's comprehensive localization s ... -
The first production and manufacturing base of Boston Scientific China has opened in Lingang, Shanghai
On October 15th, the first production and manufacturing base of Boston Scientific China opened in the Life Blue Bay Pharmaceutical Characteristic Industrial Park in the Lingang New Area of the China ... -
The Boston Science Harbor Base has been completed and opened, achieving "independent production" in China
On October 15th, the first production and manufacturing base of Boston Scientific China, the Boston Scientific Port Base, was completed and opened, focusing on the production of medical consumables a ... -
Interview with Boston Scientific's Gong Wenhao: Proactively embracing the national centralized procurement policy and accelerating the sinking of high-quality medical resources
During the 7th China International Import Expo (CIIE), Gong Wenhao, Senior Director of Coronary Intervention and Structural Heart Valve Business Unit and Technology Exploration at Boston Scientific C ... -
Goldman Sachs: Increases Boston Scientific's target price to $103
Securities Times Online News: Goldman Sachs has raised its target stock price for Boston Scientific to $103 and maintained a buy rating. Recently, several institutions have also adjusted their target ...